EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Proprotein Convertase Subtilisin/Kexin Type 9 Induces Platelet‐Derived Transforming Growth Factor‐ β to Promote Myocardial Fibrosis After Myocardial Infarction

Qianyun Wang, Wenxiang Huang, Dianmin Xia, Feifei Wang iD, Sujit Nair

Human Mutation · 2026

DOI: 10.1155/humu/4574795 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Human Mutation, 2026. Verfasst von Qianyun Wang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, The First Affiliated Hospital of Jinan University, Guangzhou, Guangdong, China, jd120.com. Hauptthemen laut MEDLINE: Proprotein Convertase 9, Myocardial Infarction, Transforming Growth Factor beta, Blood Platelets. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Guangzhou Municipal Science and Technology Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

The recovery of cardiac function after acute myocardial infarction is crucial for the prognosis of patients with myocardial infarction. Proprotein convertase subtilisin/Kexin Type 9 (PCSK9) inhibitors are widely used in patients with acute myocardial infarction due to their potent low‐density lipoprotein‐lowering effects. Recent studies have shown that elevated levels of circulating PCSK9 are associated with increased platelet reactivity and thrombosis; however, the effect and mechanism of PCSK9 on cardiac repair after myocardial infarction through the induction of platelet activation remain unclear. Therefore, the objective of this study was to investigate and clarify the specific effect of PCSK9 on cardiac repair processes following myocardial infarction. The detailed molecular and cellular mechanisms through which PCSK9 regulates cardiac repair after myocardial infarction by inducing platelet activation were observed. Methods and Results Hearts from wild‐type (WT) C57BL/6J mice and PCSK9 knockout (PCSK9 − / − ) mice were subjected to left coronary artery (LAD) ligation to establish a myocardial infarction model. Six weeks postoperation, echocardiographic analysis and Masson staining revealed that inhibiting the increase in PCSK9 expression after myocardial infarction significantly reduced myocardial fibrosis. Transcriptome sequencing of mouse myocardial tissue suggested that PCSK9 suppresses immune regulation and adhesion pathways and that the platelet marker integrin subunit alpha 2b (Itga2b) is a potential key molecule. Subsequent in vivo and in vitro experiments demonstrated that PCSK9 promotes platelet activation and induces the fibrogenic phenotypic transformation of fibroblasts by transforming growth factor‐ β (TGF‐ β ). In further studies, coculture experiments of fibroblasts and platelets revealed that PCSK9 promotes the conversion of fibroblasts to myofibroblasts by inducing platelet‐derived TGF‐ β secretion.

Conclusion

PCSK9 promotes platelet activation, induces the secretion of platelet‐derived TGF‐ β , and thereby accelerates myocardial fibrosis after myocardial infarction.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Proprotein Convertase 9Myocardial InfarctionTransforming Growth Factor betaBlood PlateletsMyocardiumAnimalsMiceFibrosisPlatelet ActivationHumansMice, KnockoutDisease Models, AnimalMice, Inbred C57BLMale

Stichwörter der Autor:innen

PCSK9myocardial fibrosisplatelet-derived TGF-β

Substanzen

Proprotein Convertase 9Transforming Growth Factor betaPcsk9 protein, mouse

Autor:innen und Institutionen

  • Department of Cardiology, The First Affiliated Hospital of Jinan University, Guangzhou, Guangdong, China, jd120.com.
  • Health Management Division, The First People's Hospital of Shunde, Foshan, Gaungdong, China.
  • Department of Oncology, The First Affiliated Hospital of Jinan University, Guangzhou, Guangdong, China, jd120.com.

ORCID-Profile: Feifei Wang

Förderung

  • Guangzhou Municipal Science and Technology Project

Zitieren

APA

Wang, Q., Huang, W., Xia, D., Wang, F., & Nair, S. (2026). Proprotein Convertase Subtilisin/Kexin Type 9 Induces Platelet‐Derived Transforming Growth Factor‐ β to Promote Myocardial Fibrosis After Myocardial Infarction. Human Mutation. https://doi.org/10.1155/humu/4574795

Vancouver

Wang Q, Huang W, Xia D, Wang F, Nair S. Proprotein Convertase Subtilisin/Kexin Type 9 Induces Platelet‐Derived Transforming Growth Factor‐ β to Promote Myocardial Fibrosis After Myocardial Infarction. Human Mutation. 2026. doi:10.1155/humu/4574795

BibTeX
@article{Wang2026,
  author = {Wang, Qianyun and Huang, Wenxiang and Xia, Dianmin and Wang, Feifei and Nair, Sujit},
  title = {Proprotein Convertase Subtilisin/Kexin Type 9 Induces Platelet‐Derived Transforming Growth Factor‐ β to Promote Myocardial Fibrosis After Myocardial Infarction},
  journal = {Human Mutation},
  year = {2026},
  doi = {10.1155/humu/4574795}
}
Kostenlos starten →